Advertisement

Less than a week after Genzyme’s Framingham plant landed approval from the European Medicines Agency to manufacture Fabrazyme,  the U.S. Food and Drug Administration has also given the OK to produce the treatment for Fabry disease.

SOURCE

Advertisement
Advertisement